NCT05611359View on ClinicalTrials.gov

Surgery and Thermal Hepatic Ablation Combined With Chemotherapy in Hepatic Oligometastatic Pancreatic Cancer

NANot yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 31, 2023

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions

Pancreatic Ductal Adenocarcinoma

Interventions

PROCEDURE

Thermal Ablation

Thermal hepatic ablation Combined with Chemotherapy

DRUG

Chemotherapy

All Listed Sponsors

lead

Second Affiliated Hospital, School of Medicine, Zhejiang University

OTHER

NCT05611359 - Surgery and Thermal Hepatic Ablation Combined With Chemotherapy in Hepatic Oligometastatic Pancreatic Cancer | Biotech Hunter | Biotech Hunter